Modular Cell Therapy Foundry for Scalable Sterile Automation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional cell therapy manufacturing processes are labor-intensive, inefficient, and not scalable, leading to low throughput, high production costs, and risks of contamination due to manual operations and operator variability.
Innovation Solution
A modular biological foundry system utilizing advanced robotics and modular design for automated manufacturing of cell therapies, enabling flexible, scalable, and sterile production of cellular engineering targets, including genetically modified immune cells, with integrated robotic systems and closed-system processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If labor-based manual processes are used for cell therapy manufacturing, then flexibility and adaptability are maintained, but productivity and scalability are severely limited
Solution Approach 1:
The manufacturing system is divided into discrete modular units (bioreactors, centrifuges, wash stations, etc.) that can be independently operated and scaled. Each module performs a specific function in the cell therapy process, allowing parallel processing of multiple batches simultaneously, thereby increasing throughput while maintaining process control.
Solution Approach 2:
The system incorporates self-monitoring and self-regulating capabilities through integrated sensors, automated control systems, and real-time data tracking. The automated machinery performs tasks without human intervention, including media addition, cell harvesting, centrifugation, and quality control sampling, eliminating operator variability and increasing productivity.
2Ease of manufacture
If highly skilled technicians manually operate each piece of equipment, then process adaptability is maintained, but manufacturing cost and operational complexity increase
Solution Approach 1:
Multiple previously separate manual operations are merged into integrated automated workstations. For example, the bioreactor system is combined with automated media delivery, monitoring, and harvesting functions. The centrifuge is integrated with automated cell collection and transfer systems. This consolidation reduces the need for skilled operators while managing complexity through standardized interfaces.
Solution Approach 2:
The automated modules are designed with universal interfaces and standardized protocols that allow them to perform multiple functions. A single workstation can handle different cell types, media formulations, and process parameters through programmable control, simplifying operations while maintaining versatility.
3Productivity
If separate individual pieces of equipment are used in series, then process flexibility is maintained, but manufacturing efficiency and throughput are reduced
Solution Approach 1:
The system performs preliminary actions by pre-programming process parameters, pre-positioning reagents, and pre-cooling equipment before cell processing begins. Automated media reservoirs are pre-filled and sterilized, centrifuge rotors are pre-balanced, and quality control kits are pre-prepared, eliminating setup time between batches and improving overall manufacturing efficiency.
Solution Approach 2:
The integrated system enables continuous processing where cells flow continuously through different processing stages without manual intervention. Automated transfer systems move cell suspensions between bioreactors, centrifuges, and wash stations without interruption. Multiple batches can be processed in parallel through different modular units simultaneously, maintaining continuous productive action throughout the facility.
Data Source
AI summary
Disclosed are devices, systems, biological foundries, and methods for facilitating automated modular manufacture of cellular engineering targets.